PBLA logo

Panbela Therapeutics (PBLA) Company Overview

Profile

Full Name:

Panbela Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 3, 2017

Indexes:

Not included

Description:

Panbela Therapeutics is a biotechnology company focused on developing innovative treatments for cancer. They aim to improve patient outcomes by creating new therapies that target specific cancer pathways. Their research includes drug development and clinical trials to bring effective solutions to patients in need.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 18, 2024

Analyst ratings

Recent major analysts updates

Aug 15, 24 HC Wainwright & Co.
Neutral
Jun 24, 24 HC Wainwright & Co.
Neutral
May 16, 24 HC Wainwright & Co.
Neutral
Apr 2, 24 HC Wainwright & Co.
Buy
Mar 27, 24 Roth MKM
Buy
Feb 5, 24 Roth MKM
Buy
Dec 18, 23 Roth MKM
Buy
Aug 11, 23 HC Wainwright & Co.
Buy
Jul 24, 23 HC Wainwright & Co.
Buy
Jul 10, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Panbela Therapeutics?
  • Does Panbela Therapeutics pay dividends?
  • What sector is Panbela Therapeutics in?
  • What industry is Panbela Therapeutics in?
  • What country is Panbela Therapeutics based in?
  • When did Panbela Therapeutics go public?
  • Is Panbela Therapeutics in the S&P 500?
  • Is Panbela Therapeutics in the NASDAQ 100?
  • Is Panbela Therapeutics in the Dow Jones?
  • When was Panbela Therapeutics's last earnings report?
  • When does Panbela Therapeutics report earnings?
  • Should I buy Panbela Therapeutics stock now?

What is the ticker symbol for Panbela Therapeutics?

The ticker symbol for Panbela Therapeutics is NASDAQ:PBLA

Does Panbela Therapeutics pay dividends?

No, Panbela Therapeutics does not pay dividends

What sector is Panbela Therapeutics in?

Panbela Therapeutics is in the Healthcare sector

What industry is Panbela Therapeutics in?

Panbela Therapeutics is in the Biotechnology industry

What country is Panbela Therapeutics based in?

Panbela Therapeutics is headquartered in United States

When did Panbela Therapeutics go public?

Panbela Therapeutics's initial public offering (IPO) was on January 3, 2017

Is Panbela Therapeutics in the S&P 500?

No, Panbela Therapeutics is not included in the S&P 500 index

Is Panbela Therapeutics in the NASDAQ 100?

No, Panbela Therapeutics is not included in the NASDAQ 100 index

Is Panbela Therapeutics in the Dow Jones?

No, Panbela Therapeutics is not included in the Dow Jones index

When was Panbela Therapeutics's last earnings report?

Panbela Therapeutics's most recent earnings report was on Feb 28, 2025

When does Panbela Therapeutics report earnings?

The date for Panbela Therapeutics's next earnings report has not been announced yet

Should I buy Panbela Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions